New scans aim to predict which breast cancer patients will respond to chemo
NCT ID NCT02744053
Summary
This early study is testing whether two advanced imaging scans can predict how well chemotherapy will work for patients with triple-negative breast cancer before they have surgery. The goal is to see if these scans can identify which patients are likely to respond to treatment. Researchers will compare these new scans to standard imaging methods to find the best way to assess treatment response early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson League City
Nassau Bay, Texas, 77058, United States
-
MD Anderson in Katy
Houston, Texas, 77094, United States
-
MD Anderson in Sugar Land
Sugar Land, Texas, 77478, United States
-
MD Anderson in The Woodlands
The Woodlands, Texas, 77384, United States
-
Memorial Hermann Memorial City Medical Center
Houston, Texas, 77024, United States
Conditions
Explore the condition pages connected to this study.